Cullinan Oncology Stock Forecast - Day Median Price
| CGEM Stock | USD 12.22 0.36 2.86% |
Cullinan Stock Forecast is based on your current time horizon. Although Cullinan Oncology's naive historical forecasting may sometimes provide an important future outlook for the firm, we recommend always cross-verifying it against solid analysis of Cullinan Oncology's systematic risk associated with finding meaningful patterns of Cullinan Oncology fundamentals over time.
Cullinan |
| Previous Day Median Price | Day Median Price | Trend |
| 12.44 | 12.44 |
| Check Cullinan Oncology Volatility | Backtest Cullinan Oncology | Information Ratio |
Cullinan Oncology Trading Date Momentum
| On November 22 2024 Cullinan Oncology LLC was traded for 12.22 at the closing time. The top price for the day was 12.84 and the lowest listed price was 12.04 . There was no trading activity during the period 0.0. Lack of trading volume on November 22, 2024 did not affect price variability. The overall trading delta against the current closing price is 2.54% . |
The median price is the midpoint of the trading periods range.
| Compare Cullinan Oncology to competition |
Other Forecasting Options for Cullinan Oncology
For every potential investor in Cullinan, whether a beginner or expert, Cullinan Oncology's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. Cullinan Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in Cullinan. Basic forecasting techniques help filter out the noise by identifying Cullinan Oncology's price trends.Cullinan Oncology Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Cullinan Oncology stock to make a market-neutral strategy. Peer analysis of Cullinan Oncology could also be used in its relative valuation, which is a method of valuing Cullinan Oncology by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
Cullinan Oncology LLC Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of Cullinan Oncology's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of Cullinan Oncology's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Cullinan Oncology Market Strength Events
Market strength indicators help investors to evaluate how Cullinan Oncology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Cullinan Oncology shares will generate the highest return on investment. By undertsting and applying Cullinan Oncology stock market strength indicators, traders can identify Cullinan Oncology LLC entry and exit signals to maximize returns.
Cullinan Oncology Risk Indicators
The analysis of Cullinan Oncology's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in Cullinan Oncology's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting cullinan stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.83 | |||
| Standard Deviation | 3.61 | |||
| Variance | 13.03 |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Historical Fundamental Analysis of Cullinan Oncology to cross-verify your projections. You can also try the Alpha Finder module to use alpha and beta coefficients to find investment opportunities after accounting for the risk.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cullinan Oncology. If investors know Cullinan will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cullinan Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.84) | Return On Assets (0.20) | Return On Equity (0.27) |
The market value of Cullinan Oncology LLC is measured differently than its book value, which is the value of Cullinan that is recorded on the company's balance sheet. Investors also form their own opinion of Cullinan Oncology's value that differs from its market value or its book value, called intrinsic value, which is Cullinan Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cullinan Oncology's market value can be influenced by many factors that don't directly affect Cullinan Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cullinan Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cullinan Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cullinan Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.